Scarica l'app Stockscreener
4.43
1.77%
-0.08
Dopo l'orario di chiusura:
4.41
-0.02
-0.45%
Precedente Chiudi:
$4.51
Aprire:
$4.55
Volume 24 ore:
51,888
Relative Volume:
0.66
Capitalizzazione di mercato:
$36.88M
Reddito:
$442.00K
Utile/perdita netta:
$-30.46M
Rapporto P/E:
-0.9933
EPS:
-4.46
Flusso di cassa netto:
$-27.47M
1 W Prestazione:
-7.90%
1M Prestazione:
-7.71%
6M Prestazione:
-14.15%
1 anno Prestazione:
-50.74%
Intervallo 1D:
$4.40
$4.70
Intervallo di 1 settimana:
$4.40
$4.99
Portata 52W:
$3.8181
$10.40
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Confronta CLNN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
4.43 | 36.88M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
31.13 | 37.80B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
61.00 | 33.63B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.66 | 28.11B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
80.14 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.65 | 16.28B | 11.92B | 805.04M | 1.01B | 1.46 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Clene Inc. (NASDAQ:CLNN) Short Interest Up 10.3% in January - Defense World
Nanotechnology Stocks To ResearchFebruary 13th - MarketBeat
Could a New Drug Help Restore Vision? Early Findings in Myelin Repair - Securities.io
7 Best Nanotech Penny Stocks to Invest In - Insider Monkey
Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? - Insider Monkey
Nanotechnology Stocks To Watch TodayFebruary 09th - MarketBeat
Promising Nanotechnology Stocks To Follow TodayFebruary 11th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnFebruary 08th - MarketBeat
Critical LDAP Vulnerability Puts Windows Systems at Risk - Experts' club
Best Nanotechnology Stocks To Watch NowFebruary 07th - MarketBeat
Promising Nanotechnology Stocks To Watch TodayFebruary 06th - MarketBeat
Nanotechnology Stocks To Follow NowFebruary 05th - MarketBeat
Promising Nanotechnology Stocks To Watch Today – February 06th - Armenian Reporter
Nanotechnology Stocks To Add to Your WatchlistFebruary 04th - MarketBeat
Clene Inc. secures additional NIH grant funds for ALS therapy - MSN
Promising Nanotechnology Stocks To Keep An Eye OnJanuary 31st - MarketBeat
Best Nanotechnology Stocks To Follow TodayJanuary 30th - MarketBeat
Clene Inc. secures additional NIH grant funds for ALS therapy By Investing.com - Investing.com UK
NATR Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus.com
Clene files to sell 1.15M shares of common stock by selling shareholders - MSN
Clene (CLNN) Stock Price, News & Analysis - MarketBeat
3 US Growth Stocks With High Insider Ownership And Revenue Growth Up To 25% - Yahoo Finance
IBN Coverage: Clene (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS - Nasdaq
Clene Secures $10 Million Debt Facility to Advance ALS Drug Development - Citybuzz
Clene (NASDAQ: CLNN) Paves Cash Runway To Advance CNM-Au8(R) For ALS - Barchart
3 US Growth Stocks With High Insider Ownership - Yahoo Finance
IBN Coverage: Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R) - Yahoo Finance
Clene Receives FDA Guidance on Potential Accelerated Approval Pathway for ALS Drug CNM-Au8 - Citybuzz
Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R) - The Globe and Mail
Clene Secures $10M Debt Facility to Enhance Position - TipRanks
Clene Secures $10 Million Debt Facility to Advance ALS and Neurodegenerative Disease Treatments - Citybuzz
IBN Coverage: Clene (NASDAQ: CLNN) Secures $10M Debt Facility to Advance Neurodegenerative Disease Treatments - Yahoo Finance
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan - The Manila Times
Real-World Evidence Helps Open Accelerated Approval Pathway For Neurodegeneration Therapies - News & Insights
Clene Inc. Provides Update on Corporate Presentation and ALS Clinical Trials - Defense World
IBN Coverage: Clene (NASDAQ: CLNN) Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathway - Yahoo Finance
Clene Receives FDA Guidance on Accelerated Approval Path for ALS Treatment CNM-Au8 - Citybuzz
Clene Gains FDA Support for ALS Treatment Approval - TipRanks
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS - The Manila Times
FDA Opens Accelerated Approval Path for Clene's Breakthrough ALS Treatment After 78% Survival Benefit - StockTitan
Clene (NASDAQ:CLNN) Given New $84.00 Price Target at Benchmark - Defense World
Clene shares hold Buy rating as analyst sees FDA decision impacting time to market - Investing.com
Roth Capital Has Bearish Forecast for Clene FY2024 Earnings - Defense World
Clene (NASDAQ:CLNN) Price Target Lowered to $83.00 at Canaccord Genuity Group - Defense World
HC Wainwright Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
AWM Investment Company, Inc. Expands Stake in Clene Inc - GuruFocus.com
Clene price target lowered to $83 from $86 at Canaccord - Yahoo Finance
ARMISTICE CAPITAL, LLC Acquires New Stake in Clene Inc - GuruFocus.com
Certain Warrants of Clene Inc. are subject to a Lock-Up Agreement Ending on 15-NOV-2024. - Marketscreener.com
Clene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.60%
2.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):